Medical/Pharmaceuticals

Supermicro Scalable Liquid-Cooled Supercomputing Cluster Deployed at Lawrence Livermore National Laboratory for COVID-19 Research

SAN JOSE, Calif., Nov. 12, 2020 /PRNewswire/ -- Super Micro Computer, Inc. (Nasdaq: SMCI), a global leader in enterprise computing, storage, networking solutions, and green computing technology, today announced that it has deployed an additional cluster at Lawrence Livermore National Laboratory (...

2020-11-12 22:00 5860

Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors

SAN DIEGO and TAICANG, SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced the ap...

2020-11-12 21:00 2160

XJTLU launches new Academy of Pharmacy

SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- On 11 November 2020, Xi'an Jiaotong-Liverpool University launched its new XJTLU Wisdom Lake Academy of Pharmacy. "The biopharmaceutical industry is one of the fastest-growing sectors worldwide," says DrYimin Ding, Vice President of XJTLU. "It is als...

2020-11-12 15:13 2118

CStone Pharmaceuticals Announces China's NMPA has Accepted its New Drug Application for anti-PD-L1 Monoclonal Antibody Sugemalimab in First-Line Advanced NSCLC

* Currently, there is no anti-PD-L1 monoclonal antibody approved for stage IV NSCLC inChina * An oral presentation of specific clinical trial data of CS1001-302 study will be given at ESMO Asia Congress onNovember 21st SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CSto...

2020-11-12 10:58 4624

B. Braun Thailand wins 'Best Company to Work for in Asia' Award

BANGKOK, Nov. 12, 2020 /PRNewswire/ -- B. Braun Thailand won the coveted 'Best Companies to Work for inAsia 2020 Award' by HR Asia on 16th October 2020. B. Braun Thailand wins ‘Best Company to Work for in Asia’ Award   B. B...

2020-11-12 09:16 2130

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

2020-11-11 17:30 6745

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

2020-11-11 16:09 4585

Monograph Published by World Scientific Publishing Proves Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer Effective in Treating COVID-19

SHANGHAI, Nov. 11, 2020 /PRNewswire/ -- Asclepius Meditec ("the Company") is pleased to announce that Hydrogen Oxygen Generator with Nebulizer – a respiratory medical device developed by the Company for combatting the coronavirus, has been featured in a monograph titled "Hydrogen-Oxygen Inhalati...

2020-11-11 15:58 2107

I Love Children Kick-starts Fertility Wellness Campaign 2020

SINGAPORE, Nov. 4, 2020 /PRNewswire/ -- I Love Children (ILC) announced today, the start of their annualKnow Your Fertility Wellness Campaign, which will continue their focus on educating couples on fertility health and creating conversations on the subject of fertility through virtual webinars w...

2020-11-11 15:00 1743

The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use

* The emergency use authorization is only granted for limited use during the pandemic, not as a product distribution approval * Data on quality, both non-clinical and clinical, as well as the public health risks are the main considerations JAKARTA, Indonesia, Nov. 11, 2020 /PRNewswire/ -- Eme...

2020-11-11 12:51 1529

Capnomed receives the Promising Startups in Asia Award at the ACES Awards 2020

STUTTGART, Germany, Nov. 11, 2020 /PRNewswire/ -- A new, inventive cutting-edge therapy (PIPAC - Pressurized IntraPeritoneal Aerosol Chemotherapy) is bringing hope to millions of cancer patients across the globe -- includingAsia. This treatment is performed using Capnomed's uniquely designed, pat...

2020-11-11 10:00 2590

Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians inAsia-Pacific with a holistic treatment approach for prediabetes and diabetes. This...

2020-11-11 10:00 3532

Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day

SAN FRANCISCO and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major diseas...

2020-11-11 08:00 8205

Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020

SAN FRANCISCO, U.S. and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other ma...

2020-11-11 08:00 6907

FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform

World Leader in Fibroblast Technology Advances Intellectual Property Position with their 250th Patent Filed Today HOUSTON, Nov. 10, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibrob...

2020-11-10 22:37 1654

Dymicron™ appoints Armen Khachatryan, M.D. to Board of Directors

OREM, Utah, Nov. 10, 2020 /PRNewswire/ -- Dymicron, a privately held, innovative medical device company developing a next generation cervical artificial disc, Triadyme-C™, with a proprietary polycrystalline diamond material and novel, Tri-Lobe articulating design, today announced thatArmen Khach...

2020-11-10 21:15 1327

German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire/ -- Vaccine manufacturers, transport and storage providers are facing major challenges in the fight against the coronavirus. MECOTEC Group has announced a complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport + 3. St...

2020-11-10 19:52 1662

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit

Low cost, high-sensitivity diagnostic test for COVID-19 detection IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ -- Zymo Research announced today that it obtained a CE IVD mark for theQuick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of the Counc...

2020-11-10 16:00 2398

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharma...

2020-11-10 09:00 2564

Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy

SINGAPORE, Nov. 10, 2020 /PRNewswire/ -- Farrer Park Hospital announced today the availability of Lutetium-177 Prostate Specific Membrane Antigen Therapy ("Lu177 PSMA Therapy"), a treatment for advanced prostate cancer.

2020-11-10 08:15 2671
1 ... 329330331332333334335 ... 397

Week's Top Stories